Document Page: First | Prev | Next | All | Image | This Release | Search

Subject: BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM TOX    

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM                                               

Document Number:          1

Folder Seq  #:        226






                                      UNCLASSIFIED


                  (2) Anthrax diagnostic kits should be positioned at medical
          treatment facilities throughout the AOR. There is a refrigeration
          requirement for these kits, but stability testing has shown the kit
          to be stable for       at temperatures of            Doctrine for
          use of these kits are

              b. Botulinum - Sign and symptoms are

          3. Treatment


              a. Anthrax

                  (1) Each SM will be issued a five day supply of
          Ciprofloxacin (Cipro) antibiotic (10 tablets in blister packs to be
          taken every 12 hours). The Cipro will not be taken
          prophylactically like pyridostigmine bromide. Cipro will be taken
          upon detection or presumption of an anthrax attack.

                  (2) Upon notification that an anthrax attack has occurred,
          the commander will direct SM to begin taking their Cipro. Each SM
          will immediately complete their three shot anthrax vaccination
          series. Additional Cipro will be resupplied by logistics channel.
          Cipro will be taken by the SM for 30 days unless otherwise directed
          by the Command Surgeon.

                  (3) Adequate supplies of the Cipro should be available.
          There                           anthrax vaccine maintained in the
          AOR designated specifically for treatment of anthrax exposed SM.
          Note that vaccination treatment is designated only for those
          anthrax exposed SM who have not developed svmptoms. CENTCOM
                                   I

              b. Botulinum Toxin (BT)

                  (1) After a BT attack, medical personnel must be vigilant
          for the appearance of BT symptoms; difficulty in talking and
          swallowing, etc). Upon appearance of symptoms, administer the




                  (2) Ventilators can be used to allow the effects of the
nt can breathe on his/her
          own. Limited numbers of ventilators will limit this approach.






                                            2


                                         UNCLASSIFIED
                                         C r-O-D F,-r
                                        1%)LUIXL I

Document Page: First | Prev | Next | All | Image | This Release | Search

Document 9 f:/Week-36/BX003203/BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM/biological warfare defense against anthrax and b:12179609290159
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM
Folder Seq # = 226
Subject = BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND B
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996